NDAORALTABLET
Approved
Jan 1967
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
EDECRIN (ethacrynic acid) by Bausch + Lomb. Approved for loop diuretic [epc]. First approved in 1967.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EDECRIN (ethacrynic acid) is a potent loop diuretic that acts on the ascending limb of the loop of Henle and proximal/distal tubules to increase urinary sodium, chloride, and water excretion. It is indicated for edema associated with congestive heart failure, hepatic cirrhosis, and renal disease. The drug works by inhibiting electrolyte reabsorption at multiple tubular sites, producing diuresis several times greater than thiazide diuretics.
$0.517MPart D
LOE ApproachingProduct is in late-stage lifecycle with minimal Part D volume ($517K spending, 229 claims in 2023), indicating a small and stable commercial footprint requiring focused maintenance rather than growth investment.
Mechanism of Action
Pharmacologic Class:
Loop Diuretic
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
EDECRIN has zero linked job openings in the dataset, reflecting its status as a legacy product with minimal active commercial infrastructure. Career opportunities are extremely limited and primarily suited to generalist roles in established product management or compliance.
Company
Worked on EDECRIN at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.